Vima Therapeutics

Vima Therapeutics is a clinical-stage biotechnology company developing novel oral therapies for movement disorders, with a focus on the underlying biology of dystonia and Parkinson's disease. Its lead program is an experimental oral therapy being evaluated in the Stride dystonia clinical study, aimed at helping patients regain control of movement rather than only managing symptoms. The company targets dystonia, dystonic cerebral palsy, and Parkinson's disease — conditions that collectively affect more than one million people in the United States. Vima was surfaced in the API Evangelist network as a portfolio company of Canaan Partners. As a patient- and clinician-facing therapeutics company, it publishes no public developer program, API, SDK, or technical documentation surface at this time.

Vima Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Movement Disorders, and Dystonia.

🌐 Visit website 📡 Source on GitHub
5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyTherapeuticsMovement DisordersDystoniaParkinson's DiseaseClinical StageLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 5.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/vima-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: vima-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/vima-therapeutics.png
name: Vima Therapeutics
description: Vima Therapeutics is a clinical-stage biotechnology company developing novel oral therapies for movement disorders,
  with a focus on the underlying biology of dystonia and Parkinson's disease. Its lead program is an experimental oral therapy
  being evaluated in the Stride dystonia clinical study, aimed at helping patients regain control of movement rather than
  only managing symptoms. The company targets dystonia, dystonic cerebral palsy, and Parkinson's disease — conditions that
  collectively affect more than one million people in the United States. Vima was surfaced in the API Evangelist network as
  a portfolio company of Canaan Partners. As a patient- and clinician-facing therapeutics company, it publishes no public
  developer program, API, SDK, or technical documentation surface at this time.
url: https://raw.githubusercontent.com/api-evangelist/vima-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-website: https://www.vimatx.com
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-api-surface: none
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Therapeutics
- Movement Disorders
- Dystonia
- Parkinson's Disease
- Clinical Stage
- Life Sciences
common:
- type: Website
  url: https://www.vimatx.com
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 0
  pass: local-v1